SCORE

31

MRTX: MIRATI THERAPEUTICS INC is a Sell


The current rating for MRTX is 31, which is 61% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.